In the present study, it was shown that melatonin oral supplementation, at the dose of 100 mg/kg/day for 8 weeks, attenuated cardiac hypertrophy and adaptive remodeling in leptin-deficient (ob/ob) mice at 13 weeks of age, before overt insulin resistance. This evidence concerns the gene LEP and cardiac hypertrophy.